Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases

por Marcos C. Vieira, Celeste M. Donato, Philip Arevalo, Guus F. Rimmelzwaan, Timothy Wood, Liza Lopez, Q. Sue Huang, Vijaykrishna Dhanasekaran, Katia Koelle, Sarah Cobey
Publicado 2021

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63

por Giulietta Saletti, Thomas Gerlach, Janina M. Jansen, Antonia Molle, Husni Elbahesh, Martin Ludlow, Wentao Li, Berend-Jan Bosch, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan
Publicado 2020

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.

por Byron E E Martina, Petra van den Doel, Penelope Koraka, Geert van Amerongen, Gunther Spohn, Bart L Haagmans, Lisette B V Provacia, Albert D M E Osterhaus, Guus F Rimmelzwaan
Publicado 2011

Avian influenza a virus in wild birds in highly urbanized areas.

por Josanne H Verhagen, Vincent J Munster, Frank Majoor, Pascal Lexmond, Oanh Vuong, Job B G Stumpel, Guus F Rimmelzwaan, Albert D M E Osterhaus, Martin Schutten, Roy Slaterus, Ron A M Fouchier
Publicado 2012

Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics

por Meiling Dai, Wenjuan Du, Carles Martínez-Romero, Tim Leenders, Tom Wennekes, Guus F. Rimmelzwaan, Frank J. M. van Kuppeveld, Ron A. M. Fouchier, Adolfo Garcia-Sastre, Erik de Vries, Cornelis A. M. de Haan
Publicado 2021

Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.

por Fatma Berri, Guus F Rimmelzwaan, Michel Hanss, Emmanuel Albina, Marie-Laure Foucault-Grunenwald, Vuong B Lê, Stella E Vogelzang-van Trierum, Patrica Gil, Eric Camerer, Dominique Martinez, Bruno Lina, Roger Lijnen, Peter Carmeliet, Béatrice Riteau
Publicado 2013

Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.

por Elisabeth G W Huijskens, Johan Reimerink, Paul G H Mulder, Janko van Beek, Adam Meijer, Erwin de Bruin, Ingrid Friesema, Menno D de Jong, Guus F Rimmelzwaan, Marcel F Peeters, John W A Rossen, Marion Koopmans
Publicado 2013

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

por Joost H C M Kreijtz, Yasemin Suezer, Gerrie de Mutsert, Geert van Amerongen, Astrid Schwantes, Judith M A van den Brand, Ron A M Fouchier, Johannes Löwer, Albert D M E Osterhaus, Gerd Sutter, Guus F Rimmelzwaan
Publicado 2009

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo

por Arwen F. Altenburg, Carolien E. van de Sandt, Bobby W. S. Li, Ronan J. MacLoughlin, Ron A. M. Fouchier, Geert van Amerongen, Asisa Volz, Rudi W. Hendriks, Rik L. de Swart, Gerd Sutter, Guus F. Rimmelzwaan, Rory D. de Vries
Publicado 2017

Correction for Koel et al., Antigenic Variation of Clade 2.1 H5N1 Virus Is Determined by a Few Amino Acid Substitutions Immediately Adjacent to the Receptor Binding Site

por Björn F. Koel, Stefan van der Vliet, David F. Burke, Theo M. Bestebroer, Eny E. Bharoto, I. Wayan W. Yasa, Inna Herliana, Brigitta M. Laksono, Kemin Xu, Eugene Skepner, Colin A. Russell, Guus F. Rimmelzwaan, Daniel R. Perez, Albert D. M. E. Osterhaus, Derek J. Smith, Teguh Y. Prajitno, Ron A. M. Fouchier
Publicado 2014

Antigenic Variation of Clade 2.1 H5N1 Virus Is Determined by a Few Amino Acid Substitutions Immediately Adjacent to the Receptor Binding Site

por Björn F. Koel, Stefan van der Vliet, David F. Burke, Theo M. Bestebroer, Eny E. Bharoto, I. Wayan W. Yasa, Inna Herliana, Brigitta M. Laksono, Kemin Xu, Eugene Skepner, Colin A. Russell, Guus F. Rimmelzwaan, Daniel R. Perez, Albert D. M. E. Osterhaus, Derek J. Smith, Teguh Y. Prajitno, Ron A. M. Fouchier
Publicado 2014